Unlock Investment Opportunities in Advanced Therapies
The ATE Investment Summit is your front-row seat to the future of biotech funding. Held on the pre-day of Advanced Therapies Europe 2025, this focused morning programme brings together Europe’s most forward-thinking investors, biotech pioneers, and strategic partners for insight-rich discussion and high-value connections. Whether you're investing in innovation or seeking it, this is where the deals begin.
A Strategic Opportunity for Biotechs, Investors — and Sponsors
The Summit is designed for action. Investors gain access to a curated cohort of startups, founders receive expert guidance and exposure, and sponsors position their brand at the epicentre of innovation. With 2025’s agenda tailored to the evolving European market, this is the most focused CGT investment platform in the region.
Whether you’re funding the future or building it, the Summit is your gateway to pre-qualified opportunities and strategic visibility.
What to Expect from the 2025 Programme
Cell and Genes most exclusive Investment Summit goes beyond panels and pitches. It’s built to spark real opportunities — through live discussions, startup showcases, and strategic networking. Backed by global leaders and investors, it sets the tone for what’s to come across the main event.
Start with macro and micro trends shaping CGT investment — from capital flows to platform-based valuations.
Biotech CEOs share real-world experiences in securing funding, navigating milestones, and scaling in complex markets.
A VC leader or industry analyst to set the tone, covering the investment climate for advanced therapies, emerging hotspots and why early-stage innovation is still worth investing in
Bringing together investors across the funding spectrum (from seed-stage VCs to growth investors) to share what drives decision making in today’s market
A showcase from 2 early-stage biotech’s outlining not just what they want from funding partners but what they need – mentorship, guidance, expertise and access to networks
A candid conversation between a biotech founder and their early investor exploring the startup journey
A rapid-fire panel / multi-perspective session on high-growth areas in biotech. Each speaker gives a 5-minute outlook on where their focus and how this aligns with market trends
Want a preview of the ATE community?
See who was in the room at last year’s event and the organisations leading the way in advanced therapies.
Download the 2024 Attendee List
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)